# FDA Inspection 868349 - Biomat USA Inc - February 20, 2014

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b3192bad-39bb-4c5f-8c28-2e9b0ed8a7ca
Source feed: FDA_Inspections

> FDA Inspection 868349 for Biomat USA Inc on February 20, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 868349
- Company Name: Biomat USA Inc
- Inspection Date: 2014-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253086 - 2024-10-31](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a908990d-4e65-4a85-9da5-b82cd0582d9c)
- [FDA Inspection 1253086 - 2024-10-31](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/28a893af-7bdd-4e91-96f0-7cf61f4ae670)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fab90cd8-1cd9-40db-ad50-137ea3cb2f08

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d